Ausgabe 11/2022
Inhalt (36 Artikel)
2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
Antoine Verger, Henryk Barthel, Nelleke Tolboom, Francesco Fraioli, Diego Cecchin, Nathalie L. Albert, Bart van Berckel, Ronald Boellaard, Matthias Brendel, Ozgul Ekmekcioglu, Franck Semah, Tatjana Traub-Weidinger, Donatienne van de Weehaeghe, Silvia Morbelli, Eric Guedj
Spatial density and tumor dosimetry are important in radiation segmentectomy with 90Y glass microspheres
Carlo Chiesa, Stefania Mazzaglia, Marco Maccauro
Unnatural amino acids offer new hope for accurate bacterial infection PET imaging in prosthetic joint infection
Peter J. H. Scott
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers—highlights from annals of Nuclear Medicine 2021
Cristiano Pini, Fabrizia Gelardi, Martina Sollini
Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”
Maria José Veloza Vega, Manuela Gallo, Gonzalo Ucros, Patricia Bernal
Total-body pediatric PET is ready for prime time
Mehdi Djekidel, Rahaf AlSadi, Maya Abi Akl, Stefaan Vandenberghe, Othmane Bouhali
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T
Eline A. M. Ruigrok, Giulia Tamborino, Erik de Blois, Stefan J. Roobol, Nicole Verkaik, Marijke De Saint-Hubert, Mark W. Konijnenberg, Wytske M. van Weerden, Marion de Jong, Julie Nonnekens
Preclinical investigations using [177Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer
Viviane J. Tschan, Francesca Borgna, Sarah D. Busslinger, Martina Stirn, Josep M. Monné Rodriguez, Peter Bernhardt, Roger Schibli, Cristina Müller
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck, Anne Schumann, Minh Nguyen, Eberhard Schneider, Jan Ungewiss, Matthias Paschke, Christian Haase, Jan L. von Hacht, Tanya Kwan, Kevin K. Lin, Jan Lenore, Thomas C. Harding, Jim Xiao, Andrew D. Simmons, Ajay-Mohan Mohan, Nicola Beindorff, Ulrich Reineke, Christiane Smerling, Frank Osterkamp
Imaging PARP with [18F]rucaparib in pancreatic cancer models
Chung Ying Chan, Zijun Chen, Gianluca Destro, Mathew Veal, Doreen Lau, Edward O’Neill, Gemma Dias, Michael Mosley, Veerle Kersemans, Florian Guibbal, Véronique Gouverneur, Bart Cornelissen
Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET)
Samantha Rossano, Takuya Toyonaga, Eric Berg, Isabella Lorence, Krista Fowles, Nabeel Nabulsi, Jim Ropchan, Songye Li, Yunpeng Ye, Zachary Felchner, David Kukis, Yiyun Huang, Helene Benveniste, Alice F. Tarantal, Stephanie Groman, Richard E. Carson
Fibrin-targeting molecular MRI in inflammatory CNS disorders
Johannes Lohmeier, Rafaela V. Silva, Anna Tietze, Matthias Taupitz, Takaaki Kaneko, Harald Prüss, Friedemann Paul, Carmen Infante-Duarte, Bernd Hamm, Peter Caravan, Marcus R. Makowski
[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity
Zachary T. Rosenkrans, Christopher F. Massey, Ksenija Bernau, Carolina A. Ferreira, Justin J. Jeffery, Jefree J. Schulte, Melissa Moore, Frank Valla, Jeanine M. Batterton, Christopher R. Drake, Alan B. McMillan, Nathan Sandbo, Ali Pirasteh, Reinier Hernandez
Applications of Generative Adversarial Networks (GANs) in Positron Emission Tomography (PET) imaging: A review
Ioannis D. Apostolopoulos, Nikolaos D. Papathanasiou, Dimitris J. Apostolopoulos, George S. Panayiotakis
Deep learning–based time-of-flight (ToF) image enhancement of non-ToF PET scans
Abolfazl Mehranian, Scott D. Wollenweber, Matthew D. Walker, Kevin M. Bradley, Patrick A. Fielding, Martin Huellner, Fotis Kotasidis, Kuan-Hao Su, Robert Johnsen, Floris P. Jansen, Daniel R. McGowan
Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT
Kathleen Weyts, Charline Lasnon, Renaud Ciappuccini, Justine Lequesne, Aurélien Corroyer-Dulmont, Elske Quak, Bénédicte Clarisse, Laurent Roussel, Stéphane Bardet, Cyril Jaudet
Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans
Ilona Polvoy, Youngho Seo, Matthew Parker, Megan Stewart, Khadija Siddiqua, Harrison S. Manacsa, Vahid Ravanfar, Joseph Blecha, Thomas A. Hope, Henry Vanbrocklin, Robert R. Flavell, Jeffrey Barry, Erik Hansen, Javier E. Villanueva-Meyer, Joanne Engel, Oren S. Rosenberg, David M. Wilson, Michael A. Ohliger
Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth
Mariska Reinartz, Emma Susanne Luckett, Jolien Schaeverbeke, Steffi De Meyer, Katarzyna Adamczuk, Dietmar Rudolf Thal, Koen Van Laere, Patrick Dupont, Rik Vandenberghe
Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT
Victor Comte, Hugo Schmutz, David Chardin, Fanny Orlhac, Jacques Darcourt, Olivier Humbert
Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation
Justin P. Wright, Jason R. Goodman, Yin-Guo Lin, Brian P. Lieberman, Jennifer Clemens, Luis F. Gomez, Qianwa Liang, Adam T. Hoye, Michael J. Pontecorvo, Kelly A. Conway
Spatial normalization and quantification approaches of PET imaging for neurological disorders
Teng Zhang, Shuang Wu, Xiaohui Zhang, Yiwu Dai, Anxin Wang, Hong Zhang, Mei Tian
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
Anna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, Michael Ljungberg, Carl Fredrik Warfvinge, Kajsa Holgersson, Andreas Hallqvist, Peter Bernhardt, Johanna Svensson
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
Aleksandra Syguła, Aleksandra Ledwon, Kornelia Hasse-Lazar, Beata Jurecka-Lubieniecka, Barbara Michalik, Ewa Paliczka-Cieślik, Marcin Zeman, Ewa Chmielik, Joanna Sczasny, Barbara Jarzab, Daria Handkiewicz-Junak
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Arnoldo Piccardo, Nathalie L. Albert, Lise Borgwardt, Frederic H. Fahey, Darren Hargrave, Norbert Galldiks, Nina Jehanno, Lars Kurch, Ian Law, Ruth Lim, Egesta Lopci, Lisbeth Marner, Giovanni Morana, Tina Young Poussaint, Victor J. Seghers, Barry L. Shulkin, Katherine E. Warren, Tatjana Traub-Weidinger, Pietro Zucchetta
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis
Egon Burian, Benjamin Palla, Nicholas Callahan, Thomas Pyka, Constantin Wolff, Claudio E. von Schacky, Annabelle Schmid, Matthias F. Froelich, Johannes Rübenthaler, Marcus R. Makowski, Felix G. Gassert
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer
Olivier Humbert, Matteo Bauckneht, Jocelyn Gal, Marie Paquet, David Chardin, David Rener, Aurelie Schiazza, Carlo Genova, Renaud Schiappa, Lodovica Zullo, Giovanni Rossi, Nicolas Martin, Florent Hugonnet, Jacques Darcourt, Silvia Morbelli, Josiane Otto
Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors
S. Ali Montazeri, Cynthia De la Garza-Ramos, Andrew R. Lewis, Jason T. Lewis, Jordan D. LeGout, David M. Sella, Ricardo Paz-Fumagalli, Zlatko Devcic, Charles A. Ritchie, Gregory T. Frey, Lucas Vidal, Kristopher P. Croome, J. Mark McKinney, Denise Harnois, Sunil Krishnan, Tushar Patel, Beau B. Toskich
Comparison of [68 Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]FDG PET/CT in colorectal cancer
Halil Kömek, Canan Can, İhsan Kaplan, Cihan Gündoğan, Ferat Kepenek, Hüseyin Karaoglan, Aykut Demirkıran, Senar Ebinç, Yunus Güzel, Ebubekir Gündeş
Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer—a single-centre experience of PET-guided biopsies
Bernd Vollnberg, Ian Alberts, Vera Genitsch, Axel Rominger, Ali Afshar-Oromieh
Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI
Riccardo Laudicella, Jan H. Rüschoff, Daniela A. Ferraro, Muriel D. Brada, Daniel Hausmann, Iliana Mebert, Alexander Maurer, Thomas Hermanns, Daniel Eberli, Niels J. Rupp, Irene A. Burger
Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography/computed tomography in newly diagnosed intermediate- to high-risk prostate cancer using histopathological evaluation of extended pelvic node dissection as reference
Rick Hermsen, Esmée B. C. Wedick, Maarten J. M. Vinken, Ludwike W. M. van Kalmthout, Heidi V. N. Küsters-Vandevelde, Charlotte H. W. Wijers, Diederik M. Somford, Jean-Paul A. van Basten
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
Wojciech Cytawa, Stefan Kircher, Hubert Kübler, Rudolf A. Werner, Simon Weber, Philipp Hartrampf, Tomasz Bandurski, Piotr Lass, Wojciech Połom, Marcin Matuszewski, Hans-Jürgen Wester, Constantin Lapa, Andreas Rosenwald, Anna Katharina Seitz, Andreas K. Buck
[18F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer
A.-L. Deleu, N. Ahmadi Bidakhvidi, L. Van Wynsberge, K. Van Laere, G. De Meerleer, K. Goffin
Prostate cancer cardiac metastasis detected on serial imaging with [68Ga] PSMA-11 PET/CT
Jeeban Paul Das, Randy Yeh
Neglected giant benign phyllode tumor of the breast
Marc-Antoine Benderra, Clement Ferrier, David Buob, Joseph Gligorov, Khaldoun Kerrou
Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T
Eline A. M. Ruigrok, Giulia Tamborino, Erik de Blois, Stefan J. Roobol, Nicole Verkaik, Marijke De Saint-Hubert, Mark W. Konijnenberg, Wytske M. van Weerden, Marion de Jong, Julie Nonnekens